Hardy K, Wu F, Tu W, Zafar A, Boulding T, McCuaig R, et al. Identification of chromatin accessibility domains in human breast cancer stem cells. Nucleus. 2016;7:50-67 pubmed publisher

Pan H, Guo M, Xiong Y, Ren J, Zhang J, Gao Q, et al. Differential proteomic analysis of umbilical artery tissue from preeclampsia patients, using iTRAQ isobaric tags and 2D nano LC-MS/MS. J Proteomics. 2015;112:262-73 pubmed publisher

Carlos C, Sonehara N, Oliani S, Burdmann E. Predictive usefulness of urinary biomarkers for the identification of cyclosporine A-induced nephrotoxicity in a rat model. PLoS ONE. 2014;9:e103660 pubmed publisher

Riopel M, Li J, Fellows G, Goodyer C, Wang R. Ultrastructural and immunohistochemical analysis of the 8-20 week human fetal pancreas. Islets. 2014;6:e982949 pubmed publisher

Comito G, Giannoni E, Di Gennaro P, Segura C, Gerlini G, Chiarugi P. Stromal fibroblasts synergize with hypoxic oxidative stress to enhance melanoma aggressiveness. Cancer Lett. 2012;324:31-41 pubmed publisher

Diesner M, Welle A, Kazanci M, Kaiser P, Spatz J, Koelsch P. In vitro observation of dynamic ordering processes in the extracellular matrix of living, adherent cells. Biointerphases. 2011;6:171-9 pubmed publisher

Yamamoto H, Mukaisho K, Sugihara H, Hattori T, Asano S. Down-regulation of FXYD3 is induced by transforming growth factor-? signaling via ZEB1/?EF1 in human mammary epithelial cells. Biol Pharm Bull. 2011;34:324-9 pubmed

Waterman R, Tomchuck S, Henkle S, Betancourt A. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS ONE. 2010;5:e10088 pubmed publisher

Zhang H, Schin M, Saha J, Burke K, Holzman L, Filipiak W, et al. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am J Physiol Renal Physiol. 2010;299:F91-8 pubmed publisher

Nakayama K, Batchelder C, Lee C, Tarantal A. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering. Tissue Eng Part A. 2010;16:2207-16 pubmed publisher

Zhang H, Saha J, Byun J, Schin M, Lorenz M, Kennedy R, et al. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol. 2008;295:F1071-81 pubmed publisher

Vehanen K, Hornof M, Urtti A, Uusitalo H. Peribulbar poloxamer for ocular drug delivery. Acta Ophthalmol. 2008;86:91-6 pubmed